Trial watch: Phase III success for Biogen's oral multiple sclerosis therapy
- PMID: 21629281
- DOI: 10.1038/nrd3465
Trial watch: Phase III success for Biogen's oral multiple sclerosis therapy
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical